目录
更新日期:2025年10月10日
姓 名 周东方 性 别
民 族 汉族 导师层次 博士导师
技术职称 教授 导师类型 学术型
最后学历 博士研究生毕业 最后学位 理学博士学位
行政职务 系总支书记 Email dfzhou@smu.edu.cn
工作单位 南方医科大学药学院 邮政编码 510515
跨学科招生
跨学科招生专业1 生物与医药 招生层次类型1 专业学位博导
跨学科招生专业2 招生层次类型2
个人简介

周东方,南方医科大学第七附属医院科技管理特派员、药学院教授、珠江医院双聘教授,博士生导师,多器官损伤防治全国重点实验室PI,国家“万人计划”青年拔尖人才(2021)。主要从事高分子(金属、蛋白多肽、硼等)药物材料及递送系统用于肿瘤及细菌感染、炎症相关疾病治疗研究。获2020年中/韩国生物材料协会青年科学家奖,入选2020年Journal of Materials Chemistry B新锐科学家。先后主持国家科技重大专项课题(1项)、国自然(3项)、中国科学院-威高研究发展计划、南方医科大学高层次人才引进和杰青培育计划,及骨干参与国家重点研发计划课题(2项)、广东省区域联合基金重点、广州市重点研发计划等项目共10余项。近年来以通讯作者在Advanced Materials、Progress in Polymer Science、Advanced Drug Delivery Reviews、Coordination Chemistry Review、Advanced Science、Nano Letters、ACS Nano、Acta Pharmaceutica Sinica B、Journal of Controlled Release、Bioactive Materials、Biomaterials等期刊发表论文70余篇,其中IF>20的7篇,H指数36,且多篇封面和高倍引。受邀担任Frontiers in Bioengineering and Biotechnology副主编,Biosafety and Health编委,The Innovation、药学学报(Acta Pharmaceutica Sinica B)、Asian Journal of Pharmaceutical Sciences、Interdisciplinary Medicine、Chinese Chemical Letters、沈阳药科大学学报等青年编委。申请中国发明专利14项,已授权8项。担任中国药理学会抗炎免疫药理专业委员会委员,中国人体健康科技促进会临床检验科学技术转化专业委员会委员,广东省精准医学研究会长青人智库委员会、纳米医学分会、分子影像分会委员等。

 

 

 

 

 

 

 

研究领域

1. (金属、蛋白多肽、硼、基因等)药物高分子材料及递送系统

2. 肿瘤及细菌感染、炎症相关疾病治疗

 

 

个人成果
  1. Tao Li, Min Ouyang, Wei Wang, Sijin Chen, Chengxingqiao Wang, Jiahui Lai, Peixian Weng, Zhenhua Li, Yupeng Wang*, Dongfang Zhou*, Engineering Red Blood Cells for Amplified Tumor Dual-Gas Transfusion Therapy. Advanced Materials, 2025, 2503206.
  2. Yupeng Wang, Jie Yu, Qiankun Shi, Zhijian Luo, Guanglong Liu, Fan Wu, Zhizhang Wang, Yubin Huang*, Dongfang Zhou*, Engineering endogenous tumor-associated macrophages-targeted biomimetic nano-RBC to reprogram tumor immunosuppressive microenvironment for enhanced chemo-immunotherapy. Advanced Materials, 2021, 33, 2103497.
  3. Zhiyun Zhang, Gaizhen Kuang, Shan Zong, Shi Liu, Haihua Xiao, Xuesi Chen, Dongfang Zhou*, Yubin Huang*, Sandwich-like fibers/sponge composite combining chemotherapy and hemostasis for efficient post-operative prevention of tumor recurrence and metastasis. Advanced Materials, 2018, 30, 1803217.
  4. Yuwei Cong#, Haihua Xiao#, Hejian Xiong, Zigui Wang, Jianxun Ding, Chan Li, Xuesi Chen*, Xing-Jie Liang*, Dongfang Zhou*, Yubin Huang, Dual drug backboned shattering polymeric theranostic nanomedicine for synergistic eradication of patient-derived lung cancer. Advanced Materials, 2018, 30, 1706220.
  5. Ting Hou#, Xiaoling Huang#, Jiahui Lai#, Dongfang Zhou*, Intra-tumoral bacteria in breast cancer and intervention strategies. Advanced Drug Delivery Reviews, 2025, 217, 115516.
  6. Haihua Xiao, Lesan Yan, Elizabeth M Dempsey, Wantong Song, Ruogu Qi, Wenliang Li, Yubin Huang, Xiabin Jing, Dongfang Zhou*, Jianxun Ding*, Xuesi Chen*, Recent progress in polymer-based platinum drug delivery systems. Progress in Polymer Science, 2018, 87, 70–106.
  7. Yingjie Yu#, Quan Xu#, Shasha He, Hejian Xiong, Qingfei Zhang, Weiguo Xu, Lei Bai, Qi Zhang, Zhiqiang Yu, Jianxun Ding*, Haihua Xiao*, Dongfang Zhou*, Recent advances in delivery of photosensitive metal-based drugs. Coordination Chemistry Review, 2019, 387, 154–179.
  8. Xiang Li#, Chengxingqiao Wang#, Junhan Liu#, Guifang Deng, Yongqiang Deng, Fang Hu, Yupeng Wang, Dongfang Zhou*, Tailoring tumor cell Golgi Apparatus-targeting self-assembled peptide for effective immunotherapy via reshaping MIF-mediated immunosuppressive network. Advanced Science, 2025, 2415133.
  9. Bo Yu#, Wei Sun#, Juntao Lin, Chaoyu Fan, Chengxingqiao Wang, Zhisen Zhang, Yupeng Wang, Yonghua Tang*, Youhui Lin*, Dongfang Zhou*, Using Cu-based metal-organic framework as a comprehensive and powerful anti-oxidant nanozyme for efficient osteoarthritis treatment. Advanced Science, 2024, 2307798.
  10. Shaobing Li, Juntao Lin, Chengxinqiao Wang, Yupeng Wang*, Yan Chen*, Dongfang Zhou*, Synergistic metabolic modulation of fibroblast-like synoviocytes with targeted dual prodrug nanoparticles to mitigate rheumatoid arthritis. Acta Pharmaceutica Sinica B, 2025,15,542–556.
  11. Yupeng Wang, Lina Wang, Tao Li, Min Ouyang, Hejian Xiong, Dongfang Zhou*, Bimetallic nanoparticles as cascade sensitizing amplifiers for low-dose and robust cancer radio-immunotherapy. Acta Pharmaceutica Sinica B, 2024, 14, 1787–1800.
  12. Yupeng Wang#, Yuwei Cong#, Manying Cai, Lina Wang, Dongfang Zhou*, Charge-conversional click polyprodrug nanomedicine for targeted and synergistic cancer therapy. Journal of Controlled Release, 2023, 356, 567–579.
  13. Jun-Hui Sun#, Xiaoling Liang#, Manying Cai, Libiao Yan, Zhengju Chen, Lei Guo, Li Jing*, Yupeng Wang* and Dongfang Zhou*, Protein-crowned Micelles for Targeted and Synergistic Tumor-Associated Macrophages Reprogramming to Enhance Cancer Treatment. Nano Letters, 2022, 22, 4410–4420.
  14. Yongyan Deng#, Yupeng Wang#, Fan Jia, Weifeng Liu, Dongfang Zhou*, Qiao Jin*, Jian Ji, Tailoring supramolecular prodrug nano-assemblies for reactive nitrogen species-potentiated chemotherapy of liver cancer. ACS Nano, 2021, 15, 8663–8675.